Web6 de abr. de 2024 · -- Onconova Therapeutics liet donderdag weten dat Chief Medical Officer Mark Gelder onlangs onverwacht is overleden. Het biofarmaceutische bedrijf in de klinische fase zei dat het niet verwacht dat... 12 april 2024 WebHá 1 dia · In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower ...
Onconova Therapeutics, Inc. (ONTX) - Yahoo!
WebOnconova Therapeutics, Inc. (ONTX) Reports Q3 Loss, Misses Revenue Estimates. Onconova Therapeutics, Inc. (ONTX) delivered earnings and revenue surprises of -23.81% and 5%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock? WebONTX Complete Onconova Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. the paper ceiling.org
ONTX Onconova Therapeutics Inc - Stocktwits
Web11 de abr. de 2024 · The company reported ($0.59) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.56) by ($0.03). The firm had revenue of $100.23 million for the quarter, compared to ... Web4 de jun. de 2024 · Onconova Therapeutics, Inc. (ONTX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. Web6 de abr. de 2024 · Onconova Therapeutics, Inc. (NASDAQ:ONTX) Expected to Post Q1 2024 Earnings of ($0.27) Per Share americanbankingnews.com - March 21 at 1:20 AM: Onconova Therapeutics, Inc. (NASDAQ:ONTX) Q4 2024 Earnings Call Transcript finance.yahoo.com - March 18 at 9:55 AM: H.C. Wainwright Sticks to Its Hold Rating for … shuttle brussels airport to maastricht